Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
OssDsign to IPO on Nasdaq First North
May 24, 2019

Nasdaq has announced that the trading of OssDsign will be commenced today on Nasdaq First North in Stockholm. OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved Healing of bone defects. OssDsign reported sales of SEK 8.8m with EBIT of SEK -49m in 2017.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: